197 Results

People

  1. Ladanyi
    Ladanyi
  2. Kris
    Kris
  3. Riely
    Riely
  4. Solit
    Solit
  5. Arcila
    Arcila
  6. O'Reilly
    O'Reilly
  7. Rusch
    Rusch
  8. Schultz
    Schultz
  9. Basturk
    Basturk
  10. Shia
    Shia

Groups

  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)
  7. Center for Pancreatic Cancer Research (49)
  8. Thoracic Oncology (47)
  9. Gastrointestinal Oncology Service (43)
  10. Tow Center for Developmental Oncology (TCDO) (43)
  1. "k ras protein"
Formats
  1. Journal Article (182)
  2. Review (10)
  3. Editorial (4)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)

More Groups

People
  1. Marc Ladanyi (32)
  2. Mark Kris (24)
  3. Gregory Riely (21)
  4. David Solit (16)
  5. Maria Arcila (13)
  6. Maureen Zakowski (13)

More People

Years
  1. 2025 (14)
  2. 2024 (23)
  3. 2023 (11)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (14)

More Years

Publications
  1. Clinical Cancer Research (12)
  2. Journal of Thoracic Oncology (10)
  3. Proceedings of the National Academy of Sciences of the United States of America (8)
  4. Cancer Cell (7)
  5. Modern Pathology (7)
  6. Journal of Clinical Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. American Association for Cancer Research (24)
  3. Cell Press (14)
  4. Wiley Blackwell (14)
  5. Nature Publishing Group (13)
  6. Lippincott Williams & Wilkins (12)

More Publishers

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) cytosine (FAC) in human orthotopic and genetically modified mouse pancreatic cancer models
    Journal Article

    Russell, J.; Pillarsetty, N.; Kramer, R. M.; Romesser, P. B.; Desai, P.; Haimovitz-Friedman, A.; Lowery, M. A.; Humm, J. L.
    Molecular Imaging and Biology (2017)

    Fulltext@MSK | Save
  • HMG-CoA synthase 1 is a synthetic lethal partner of BRAF(V600E) in human cancers
    Journal Article

    Zhao, L.; Fan, J.; Xia, S.; Pan, Y.; Liu, S.; Qian, G.; Qian, Z.; Kang, H. B.; Arbiser, J. L.; Pollack, B. P.; more...
    Journal of Biological Chemistry (2017)

    Fulltext@MSK | Save
  • Identification and targeting of kinase alterations in histiocytic neoplasms
    Journal Article

    Ozkaya, N.; Dogan, A.; Abdel-Wahab, O.
    Hematology/Oncology Clinics of North America (2017)

    Fulltext@MSK | Save
  • EGFR gene amplification and KRAS mutation predict response to combination targeted therapy in metastatic colorectal cancer
    Journal Article

    Khan, S. A.; Zeng, Z.; Shia, J.; Paty, P. B.
    Pathology & Oncology Research (2017)

    Fulltext@MSK | Save
  • IGFBP-3 gene methylation in primary tumor predicts recurrence of stage II colorectal cancers
    Journal Article

    Fu, T.; Pappou, E. P.; Guzzetta, A. A.; De Freitas Calmon, M.; Sun, L.; Herrera, A.; Li, F.; Wolfgang, C. L.; Baylin, S. B.; Iacobuzio-Donahue, C. A.; more...
    Annals of Surgery (2016)

    Fulltext@MSK | Save
  • Genetic diversity of pancreatic ductal adenocarcinoma and opportunities for precision medicine
    Journal Article

    Knudsen, E. S.; O'Reilly, E. M.; Brody, J. R.; Witkiewicz, A. K.
    Gastroenterology (2016)

    Fulltext@MSK | Save
  • Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer
    Journal Article

    Kopetz, S.; Desai, J.; Chan, E.; Hecht, J. R.; O'Dwyer, P. J.; Maru, D.; Morris, V.; Janku, F.; Dasari, A.; Chung, W.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition
    Journal Article

    Garcia-Rendueles, M. E. R.; Ricarte-Filho, J. C.; Untch, B. R.; Landa, I.; Knauf, J. A.; Voza, F.; Smith, V. E.; Ganly, I.; Taylor, B. S.; Persaud, Y.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants
    Journal Article

    Hechtman, J. F.; Sadowska, J.; Huse, J. T.; Borsu, L.; Yaeger, R.; Shia, J.; Vakiani, E.; Ladanyi, M.; Arcila, M. E.
    Molecular Cancer Research (2015)

    Fulltext@MSK | Save
  • Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches
    Journal Article

    Drilon, A.; Wang, L.; Arcila, M. E.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; Kris, M. G.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save